HITEN acquired 350,000 shares of Livero (9245) from President and Representative Director Hidetoshi Kashima on Sept. 30, 2026, representing 6.56% of total shareholder voting rights, the Tokyo Stock Exchange Growth-listed company said.
Because the acquisition amounts to 5% or more of voting rights, it constitutes a "purchase equivalent to a tender offer" as defined under Article 167, Paragraph 1 of Japan's Financial Instruments and Exchange Act and Article 31 of its Enforcement Order, according to the filing.
Livero said it made the disclosure at the request of HITEN, the acquirer, pursuant to Article 30, Paragraph 1, Item 4 of the Enforcement Order. HITEN, whose representative director is Keiko Kashima, issued a separate notice the same day saying it had decided to acquire the shares from Hidetoshi Kashima.
Both releases said HITEN intends to hold the shares over the long term as a stable shareholder.
| Item | Figure |
|---|---|
| Shares acquired | 350,000 |
| Acquisition date | Sept. 30, 2026 |
| Share of total voting rights | 6.56% |
| Total voting rights (June 30, 2026) | 53,383 |
The voting-rights ratio was calculated against 53,383 total shareholder voting rights as of June 30, 2026, rounded to two decimal places. Livero's share trading unit is 100 shares.
| Hikari Tsushin, Inc. | |
| Offer price | ¥1,000 per common share |
| M&A / TOB | 1 |
| Guidance | 0 |
| Buybacks | 0 |
| Dividends | 0 |
| Capital | 0 |
| Earnings | 0 |
| People | 0 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理，非投資建議，亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。